Results of Low-Dose Carperitide Infusion in High-Risk Patients Undergoing Coronary Artery Bypass Grafting

In the early postoperative period, carperitide has a cardiorenal protective effect that prevents postoperative MACCE and hemodialysis. Perioperative low-dose carperitide infusion may be useful in high-risk patients undergoing on-pump CABG.